
Merck & Co., Inc. (MRK)
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn moreNews headlines
Powered by Yahoo ScoutMerck’s third-quarter results showed continued growth from Keytruda, Winrevair, and animal health. The central investment issue remains replacing Keytruda revenue before U.S. patent expirations begin in 2028, while Gardasil and 2027 growth create nearer-term uncertainties.









